JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1990; 16:137-142
© 1990 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Julien, J
Right arrow Articles by Corvol, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Julien, J
Right arrow Articles by Corvol, P

Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison

J Julien, MA Dufloux, R Prasquier, G Chatellier, D Menard, PF Plouin, J Menard, and P Corvol

Service d'Hypertension Arterielle, Hopital Broussais, Paris, France.

In a double-blind 6 month trial, the cardiac effects of captopril and minoxidil, administered as third step treatments, were compared in 34 men with essential hypertension and diastolic blood pressure greater than 95 mm Hg who were taking 200 mg/day of metoprolol and 80 mg/day of furosemide. Average daily doses of captopril and minoxidil were 269 mg (range 150 to 300) and 20 mg (range 7.5 to 30), respectively. At the end of the 6 months' treatment, blood pressure had dropped significantly in both groups, but echocardiographic criteria of hypertrophy improved only in the captopril group (intragroup comparison): blood pressure, thickness of the intraventricular septum and posterior wall, and the left ventricular mass index, respectively, decreased from 163/102 to 135/89 mm Hg (p less than 0.001), 17.4 to 15.9 mm (p less than 0.05), 14.5 to 13.4 mm (p less than 0.05) and 236 to 198 g/m2 (p less than 0.001). In the minoxidil group, blood pressure dropped from 160/99 to 137/87 mm Hg (p less than 0.001), but echocardiographic criteria were not significantly modified. Fractional shortening remained normal in both groups. These results show that in patients with severe left ventricular hypertrophy, captopril-based triple therapy reduces left ventricular mass without altering systolic performance, whereas minoxidil-based therapy does not.


This article has been cited by other articles:


Home page
 HypertensionHome page
F. H. H. Leenen and B. Yuan
Mortality After Coronary Artery Occlusion in Different Models of Cardiac Hypertrophy in Rats
Hypertension, February 1, 2001; 37(2): 209 - 215.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
K. Lindpaintner, M. Lee, M. G. Larson, V. S. Rao, M. A. Pfeffer, J. M. Ordovas, E. J. Schaefer, A. F. Wilson, P. W.F. Wilson, R. S. Vasan, et al.
Absence of Association or Genetic Linkage between the Angiotensin-Converting-Enzyme Gene and Left Ventricular Mass
N. Engl. J. Med., April 18, 1996; 334(16): 1023 - 1028.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
J. R. Petersen, H. Drabaek, G. Gleerup, J. Mehlsen, L. Juhl Petersen, and K. Winther
ACE Inhibition with Spirapril Improves Diastolic Function at Rest Independent of Vasodilation During Treatment with Spirapril in Mild to Moderate Hypertension
Angiology, March 1, 1996; 47(3): 233 - 240.
[Abstract] [PDF]

Home page
 HypertensionHome page
M. Lievre, P. Gueret, C. Gayet, R. Roudaut, M. C. Haugh, S. Delair, and J.-P. Boissel
Ramipril-Induced Regression of Left Ventricular Hypertrophy in Treated Hypertensive Individuals
Hypertension, January 1, 1995; 25(1): 92 - 97.
[Abstract] [Full Text]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1990 by the American College of Cardiology Foundation.